Noninvasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection

American Journal of Obstetrics and Gynecology

Volumn 187, Issue 5, 2002, Pages 1290-1293

  Cosmi, Erich ^a   Mari, Giancarlo ^a   Chiaie, Loredana Delle ^b   Detti, Laura ^a   Akiyama, Masashi ^a   Murphy, June ^c   Stefos, Theodor ^d   Ferguson II, James E ^a   Hunter, David ^f   Hsu, Chaur Dong ^g   Abuhamad, Alfred ^e   Bahado Singh, Ray ^c  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF ULM   (Germany)

^c YALE UNIVERSITY   (United States)

^d UNIVERSITY OF IOANNINA   (Greece)

^e EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^f NORWALK HOSPITAL   (United States)

^g UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

Author keywords

Doppler; Fetal anemia; Middle cerebral artery peak systolic velocity; Parvovirus infection

Indexed keywords

ANEMIA; ASCITES; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONFERENCE PAPER; CORDOCENTESIS; DIAGNOSTIC ACCURACY; DOPPLER ECHOGRAPHY; FETUS; FETUS ECHOGRAPHY; GESTATIONAL AGE; HUMAN; HYDROPS; MIDDLE CEREBRAL ARTERY; PARVOVIRUS; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0036854204     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2002.128024     Document Type: Conference Paper

References (26)

1. Gay NJ, Hesketh LM, Cohen BJ, Rush M, Bates C, Morgan-Capner B, et al. Age specific antibody prevalence to parvovirus B19: How many women are infected in pregnancy? Commun Dis Rep CDR Wkly 1994;4: 104-7.
2. Public Health Laboratory Service Working Party on Fifth Disease. Prospective study of human parvovirus (B19) infection in pregnancy. BMJ 1990;300: 1166-70.
3. Brown KE, Young NS. Parvovirus B19 infection and hematopoiesis. Blood Rev 1995;9: 176-82.
4. Forestier F, Tissot JD, Vial Y, Daffos F, Hohlfeld P. Hematological parameters of parvovirus B19 infection in 13 fetuses with hydrops foetalis. Br J Haematol 1999;104: 925-7.
5. Porter HJ, Quantrill AM, Fleming KA. B19 Parvovirus infection of myocardial cells. Lancet 1988;1: 535-6.
6. Morey AL, Nicolini U, Welch CR, Economides D, Chamberlain PF, Cohen BJ. Parvovirus B19 infection and transient fetal hydrops. Lancet 1991;337: 496.
7. Nicolaides KH, Soothill PW, Clewell WH, Rodeck CH, Mibasham RS, Campbell S. Fetal hemoglobin measurement in the assessment of red cell alloimmunization. Lancet 1988;1: 1073-5.
8. Mari G, Deter RL, Carpenter RL, Rahman F, Zimmerman R, Moise KJ Jr, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. N Engl J Med 2000;342: 9-14.
9. Delle Chiaie L, Buck G, Grab D, Terinde R. Prediction of fetal anemia with Doppler measurement of the middle cerebral artery peak systolic velocity in pregnancies complicated by maternal blood group alloimmunization or parvovirus B19 infection. Ultrasound Obstet Gynecol 2001;18: 232-6.
10. Mari G, Adrignolo A, Abuhamad AZ, Pirhonen PY, Jones CD, Ludomirsky A, et al. Diagnosis of fetal anemia with Doppler ultrasound in the pregnancy complicated by maternal blood group immunization. Ultrasound Obstet Gynecol 1995;5: 400-5.
11. Detti L, Oz U, Guney I, Bahado-Singh R, Ferguson JE II, Mari G. Doppler ultrasound velocimetry for timing the second transfusion in fetuses with anemia from red cell alloimmunization. Am J Obstet Gynecol 2001;185: 1048-51.
12. Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998;105: 174-8.
13. Torok TJ. Human parvovirus B19 infections in pregnancy. Pediatr Infect Dis J 1990;9: 772-6.
14. Levy R, Weissman A, Blomberg G, Hagart ZJ. Infection by parvovirus B19 during pregnancy: A review. Obstet Gynecol Surv 1997;52: 254-9.
15. Hall J. Parvovirus B19 infection during pregnancy and its associated disease. Arch Dis Child Fetal Neonatal Ed 1994;71: F4-5.
16. Markenson GR, Yancey MK. Parvovirus B 19 infections in pregnancy. Semin Perinatol 1988;22: 309-17.
17. Rodis JF, Borgida AF, Wilson M, Egan JFX, Leo MV, Odibo AO, et al. Management of parvovirus infection in pregnancy and outcomes of hydrops: A survey of members of the society of perinatal obstetricians. Am J Obstet Gynecol 1998;179: 985-8.
18. Sheik AU, Ernest JM, O'Shea M. Long-term outcome in fetal hydrops from parvovirus B19 infections. Am J Obstet Gynecol 1992;167: 237-41.
19. Smolenic JS, Pillai M. Management of fetal hydrops associated with parvovirus B19 infection. Br J Obstet Gynaecol 1994;101: 1079-81.
20. Fairley CK, Smolenic JS, Caul OE, Miller E. Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection. Lancet 1995;346: 1335-7.
21. American College of Obstetricians and Gynecologists. Perinatal Viral and Parasitic Infections: Washington (DC): The College; 2000. Practice Bulletin No.: 20.
22. Humprey W, Magoon M, O'Shaughnessy R. Severe nonimmune hydrops secondary to parvovirus B19 infection: Spontaneous reversal in utero and survival of a term infant. Obstet Gynecol 1991;78: 900-2.
23. Pryde PC, Nugent CE, Pridjian G, Barr M Jr, Faix RG. Spontaneous resolution of nonimmune hydrops retails secondary to human parvovirus B 19 infection. Obstet Gynecol 1992;79: 859-61.
24. Detti L, Mari G, Akiyama M, Cosmi E, Moise KJ, Stefos T, et al. Longitudinal assessment of the mild cerebral artery peak systolic velocity in normal fetuses and in fetuses at risk for anemia. Am J Obstet Gynecol 2002;187: 937-9.
25. Mari G, Detti L, Oz U, Zimmermann R, Duerig P, Stefos T. Accurate prediction of fetal hemoglobin by Doppler ultrasonography. Obstet Gynecol 2002;99: 589-93.
26. Zimmerman R, Durig P, Carpenter RJ, Mari G. Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation: A prospective multicentre trial with intention to treat. Br J Obstet Gynaecol 2002;109: 746-52.